Skip to main content
. 2020 Apr 29;11:435. doi: 10.3389/fmicb.2020.00435

TABLE 1.

PICOS framework for determination of eligibility of review question.

Criteria Determinants
Problem Anecdotal data suggests that MET, a drug used to treat type II diabetes mellitus, affects the ability of macrophages to control intracellular Mtb.
Intervention Does MET affect the ability of macrophages to control intracellular Mtb.
Comparison Absence of MET.
Outcomes Effect on macrophage phagolysosomal activity.
Synergistic effect with current TB therapy.
Study setting Includes studies worldwide.

MET, metformin; Mtb, Mycobacterium tuberculosis; PICOS, Population/Problem, Intervention, Comparison, Outcomes and Study setting; TB, tuberculosis.